Bradley Foster & Sargent’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.66M | Sell |
|
|||||
|
2025
Q2 | $3.86M | Buy |
|
|||||
|
2025
Q1 | $3.45M | Sell |
|
|||||
|
2024
Q4 | $4.97M | Sell |
|
|||||
|
2024
Q3 | $7.08M | Sell |
|
|||||
|
2024
Q2 | $9.6M | Buy |
|
|||||
|
2024
Q1 | $8.25M | Buy |
|
|||||
|
2023
Q4 | $6.55M | Buy |
|
|||||
|
2023
Q3 | $5.59M | Sell |
|
|||||
|
2023
Q2 | $5.59M | Buy |
|
|||||
|
2023
Q1 | $5.47M | Sell |
|
|||||
|
2022
Q4 | $4.93M | Hold |
|
|||||
|
2022
Q3 | $3.63M | Sell |
|
|||||
|
2022
Q2 | $4.08M | Buy |
|
|||||
|
2022
Q1 | $3.99M | Sell |
|
|||||
|
2021
Q4 | $4.04M | Sell |
|
|||||
|
2021
Q3 | $3.52M | Buy |
|
|||||
|
2021
Q2 | $3.03M | Buy |
|
|||||
|
2021
Q1 | $2.4M | Sell |
|
|||||
|
2020
Q4 | $2.49M | Buy |
|
|||||
|
2020
Q3 | $2.45M | Buy |
|
|||||
|
2020
Q1 | $2.12M | Sell |
|
|||||
|
2019
Q4 | $2.04M | Buy |
|
|||||
|
2019
Q3 | $1.8M | Sell |
|
|||||
|
2019
Q2 | $1.8M | Sell |
|
|||||
|
2019
Q1 | $1.97M | Hold |
|
|||||
|
2018
Q4 | $1.74M | Sell |
|
|||||
|
2018
Q3 | $1.85M | Buy |
|
|||||
|
2018
Q2 | $270K | Hold |
|
|||||
|
2018
Q1 | $288K | Buy |
|
|||||
|
2017
Q4 | $313K | Sell |
|
|||||
|
2017
Q3 | $303K | Sell |
|
|||||
|
2017
Q2 | $275K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $298K | Sell |
|
|||||
|
2016
Q3 | $1.7M | Buy |
|
|||||
|
2016
Q2 | $2.11M | Buy |
|
|||||
|
2016
Q1 | $2.09M | Buy |
|
|||||
|
2015
Q4 | $2.06M | Buy |
|
|||||
|
2015
Q3 | $1.83M | Buy |
|
|||||
|
2015
Q2 | $1.73M | Buy |
|
|||||
|
2015
Q1 | $1.38M | Buy |
|
|||||
|
2014
Q4 | $862K | Buy |
|
|||||
|
2014
Q3 | $848K | Buy |
|
|||||
|
2014
Q2 | $605K | Buy |
|
|||||
|
2014
Q1 | $457K | Sell |
|
|||||
|
2013
Q4 | $370K | Buy |
|
|||||
|
2013
Q3 | $335K | Buy |
|
|||||
|
2013
Q2 | $287K | Buy |
|